> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# 2 Teva NDAs Approved for Asthma Products
- URL: https://www.fdaweb.com/2-teva-ndas-approved-for-asthma-products/
- Published: 2017-01-30T12:00:00.000Z
- Updated: 2026-09-14T22:03:39.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5137852

FDA has approved two Teva Pharmaceutical Industries NDAs for AirDuo RespiClick (fluticasone propionate and salmeterol inhalation powder) and ArmonAir RespiClick (fluticasone propionate inhalation powder), both indicated for use in asthma patients. AirDuo is a fixed dose combination product containing the same active ingredients as GlaxoSmithKline’s Advair, indicated for treating asthma in patients aged 12 years and older. ArmonAir is an inhaled corticosteroid containing the same active ingredient as Glaxo’s Flovent, indicated for the maintenance treatment of asthma in patients 12 years and older.